Predictive Oncology (NASDAQ:POAI) Shares Pass Below 200-Day Moving Average of $1.65

Predictive Oncology Inc. (NASDAQ:POAI)’s share price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $1.65 and traded as low as $0.90. Predictive Oncology shares last traded at $0.91, with a volume of 26,789 shares.

Analyst Ratings Changes

Separately, HC Wainwright started coverage on shares of Predictive Oncology in a report on Monday, August 19th. They issued a “buy” rating and a $3.00 price target for the company.

Predictive Oncology Stock Performance

The company has a 50-day simple moving average of $1.03 and a 200-day simple moving average of $1.63.

Predictive Oncology (NASDAQ:POAI) last released its earnings results on Tuesday, August 13th. The medical instruments supplier reported ($0.68) earnings per share for the quarter. The business had revenue of $0.28 million during the quarter. Predictive Oncology had a negative return on equity of 200.06% and a negative net margin of 802.69%. As a group, equities research analysts forecast that Predictive Oncology Inc. will post -2.03 EPS for the current fiscal year.

Predictive Oncology Company Profile

Predictive Oncology Inc operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples.